Vasoactive intestinal peptide as a new drug for treatment of primary pulmonary hypertension
J. Clin. Invest. Ventzislav Petkov, et al. 111:1339 doi:10.1172/JCI17500 [Go to this article.]

Table 1
Baseline characteristics of the patients
Copyright © 2008, The American Society for Clinical Investigation.
Copying, redistribution, and other usage policies